Comparison of serum Concentration of Se, Pb, Mg, Cu, Zn, between MS patients and healthy controls

Anahita Alizadeh1, Omid Mehrpour2, Karim Nikkhah3

  • 1MD, Pediatrician, Fellowship of Toxicology, Assistant Professor, Department of Clinical Toxicology, Mashhad University of Medical Sciences, Mashhad, Iran.

Electronic Physician
|October 21, 2016
PubMed
Abstract

Insights

This study found no significant differences in serum levels of Selenium, Zinc, Copper, and Lead between Multiple Sclerosis (MS) patients and healthy controls. However, Magnesium levels were significantly lower in MS patients, though still within the normal range.

Area of Science:

  • Environmental toxicology
  • Neuroimmunology
  • Clinical chemistry

Background:

  • Multiple Sclerosis (MS) is a common inflammatory autoimmune disorder with unclear etiology.
  • Environmental factors and genetics are implicated in MS development.
  • This study investigated the role of specific metals in MS patients.

Purpose of the Study:

  • To evaluate the potential association between serum levels of Selenium (Se), Zinc (Zn), Copper (Cu), Lead (Pb), and Magnesium (Mg) and Multiple Sclerosis (MS).

Main Methods:

  • A cross-sectional study involving 26 MS patients and 30 healthy controls.
  • Serum metal concentrations (Se, Zn, Cu, Pb, Mg) were measured using atomic absorption spectrophotometry and an autoanalyzer.
  • Statistical comparison between groups included independent-samples t-test and Mann-Whitney U test.

Main Results:

  • No significant differences in serum concentrations of Zn, Cu, Se, and Pb were observed between MS patients and controls.
  • Serum Magnesium (Mg) levels were significantly lower in MS patients compared to healthy controls (p=0.001).

Conclusions:

  • Serum levels of Zn, Pb, Se, and Cu were not significantly different between MS patients and genetically matched controls.
  • MS patients exhibited significantly lower serum Mg levels, although these remained within the normal physiological range.

Related Concept Videos